| Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole DM Musher, S Aslam, N Logan, S Nallacheru, I Bhaila, F Borchert, ... Clinical infectious diseases 40 (11), 1586-1590, 2005 | 635 | 2005 |
| Treatment of Clostridium difficile-associated disease: old therapies and new strategies S Aslam, RJ Hamill, DM Musher The Lancet infectious diseases 5 (9), 549-557, 2005 | 540 | 2005 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 511 | 2021 |
| Combination of Tigecycline and N-Acetylcysteine Reduces Biofilm-Embedded Bacteria on Vascular Catheters S Aslam, BW Trautner, V Ramanathan, RO Darouiche Antimicrobial agents and chemotherapy 51 (4), 1556-1558, 2007 | 158 | 2007 |
| Role of antibiofilm-antimicrobial agents in controlling device-related infections S Aslam, RO Darouiche The International journal of artificial organs 34 (9), 752-758, 2011 | 156 | 2011 |
| Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient N Law, C Logan, G Yung, CLL Furr, SM Lehman, S Morales, F Rosas, ... Infection 47, 665-668, 2019 | 155 | 2019 |
| Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States S Aslam, E Lampley, D Wooten, M Karris, C Benson, S Strathdee, ... Open forum infectious diseases 7 (9), ofaa389, 2020 | 152 | 2020 |
| The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ … S Husain, A Sole, BD Alexander, S Aslam, R Avery, C Benden, EM Billaud, ... The Journal of Heart and Lung Transplantation 35 (3), 261-282, 2016 | 150 | 2016 |
| Effect of antibacterials on biofilms S Aslam American journal of infection control 36 (10), S175. e9-S175. e11, 2008 | 150 | 2008 |
| Early clinical experience of bacteriophage therapy in 3 lung transplant recipients S Aslam, AM Courtwright, C Koval, SM Lehman, S Morales, CLL Furr, ... American Journal of Transplantation 19 (9), 2631-2639, 2019 | 149 | 2019 |
| Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients CX Qin, LW Moore, S Anjan, R Rahamimov, CD Sifri, NM Ali, MK Morales, ... Transplantation 105 (11), e265, 2021 | 133 | 2021 |
| An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection S Kusne, M Mooney, L Danziger-Isakov, A Kaan, LH Lund, H Lyster, ... The Journal of Heart and Lung Transplantation 36 (10), 1137-1153, 2017 | 129 | 2017 |
| An update on diagnosis, treatment, and prevention of Clostridium difficile–associated disease S Aslam, DM Musher Gastroenterology Clinics 35 (2), 315-335, 2006 | 121 | 2006 |
| Systematic review and meta-analysis on management of hemodialysis catheter-related bacteremia S Aslam, F Vaida, M Ritter, RL Mehta Journal of the American Society of Nephrology 25 (12), 2927-2941, 2014 | 105 | 2014 |
| The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera R Rathnasinghe, S Jangra, A Cupic, C Martínez-Romero, LCF Mulder, ... MedRxiv, 2021 | 101 | 2021 |
| Risk factors and outcomes of fungal ventricular-assist device infections S Aslam, M Hernandez, J Thornby, B Zeluff, RO Darouiche Clinical infectious diseases 50 (5), 664-671, 2010 | 100 | 2010 |
| COVID-19: yet another coronavirus challenge in transplantation S Aslam, MR Mehra The Journal of Heart and Lung Transplantation 39 (5), 408-409, 2020 | 96 | 2020 |
| Clinical effectiveness of COVID‐19 vaccination in solid organ transplant recipients S Aslam, E Adler, K Mekeel, SJ Little Transplant Infectious Disease 23 (5), e13705, 2021 | 82 | 2021 |
| Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a … APS Munro, S Feng, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, ... The Lancet Infectious Diseases 22 (8), 1131-1141, 2022 | 78 | 2022 |
| Considerations for the use of phage therapy in clinical practice GA Suh, TP Lodise, PD Tamma, JM Knisely, J Alexander, S Aslam, ... Antimicrobial agents and chemotherapy 66 (3), e02071-21, 2022 | 77 | 2022 |
